sodium fusidate Cutaneous ointment 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19732
This young, rapidly growing pharmaceutical company focuses on providing high-quality formulations and topical applications across multiple therapy areas. Headquartered in India with manufacturing facilities located within the country, they serve markets globally. The company's portfolio includes prescription medications, over-the-counter drugs, and potentially medical devices or supplements, although specifics are not provided. They emphasize a commitment to quality, aligning their policies with global pharmaceutical trends and holding relevant GMP certifications. While specific therapy areas, dosage forms, and patent information are not mentioned, the company highlights its strong growth trajectory, reaching a turnover of 35 crores in the last financial year.
None